de Boer RA, De Keulenaer G, Bauersachs J, Brutsaert D, Cleland JG, Diez J, Du XJ, Ford P, Heinzel FR, Lipson KE et al (2019) Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. Eur J Heart Fail 21:272–285. https://doi.org/10.1002/ejhf.1406

Article  PubMed  PubMed Central  Google Scholar 

Yang EY, Ghosn MG, Khan MA, Gramze NL, Brunner G, Nabi F, Nambi V, Nagueh SF, Nguyen DT, Graviss EA et al (2019) Myocardial extracellular volume fraction adds prognostic information beyond myocardial replacement fibrosis. Circ Cardiovasc Imaging 12:e009535. https://doi.org/10.1161/CIRCIMAGING.119.009535

Article  PubMed  PubMed Central  Google Scholar 

Chen IY, Wu JC (2011) Cardiovascular molecular imaging: focus on clinical translation. Circulation 123:425–443. https://doi.org/10.1161/CIRCULATIONAHA.109.916338

Article  PubMed  PubMed Central  Google Scholar 

McLellan MA, Skelly DA, Dona MSI, Squiers GT, Farrugia GE, Gaynor TL, Cohen CD, Pandey R, Diep H, Vinh A et al (2020) High-Resolution transcriptomic profiling of the heart during chronic stress reveals cellular drivers of cardiac fibrosis and hypertrophy. Circulation 142:1448–1463. https://doi.org/10.1161/CIRCULATIONAHA.119.045115

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frangogiannis NG (2019) The extracellular matrix in ischemic and nonischemic heart failure. Circ Res 125:117–146. https://doi.org/10.1161/CIRCRESAHA.119.311148

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alexanian M, Przytycki PF, Micheletti R, Padmanabhan A, Ye L, Travers JG, Gonzalez-Teran B, Silva AC, Duan Q, Ranade SS et al (2021) A transcriptional switch governs fibroblast activation in heart disease. Nature 595:438–443. https://doi.org/10.1038/s41586-021-03674-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Farbehi N, Patrick R, Dorison A, Xaymardan M, Janbandhu V, Wystub-Lis K, Ho JW, Nordon RE, Harvey RP (2019) Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury. Elife. https://doi.org/10.7554/eLife.43882

Article  PubMed  PubMed Central  Google Scholar 

Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC (2016) Cardiac fibrosis: The fibroblast awakens. Circ Res 118:1021–1040. https://doi.org/10.1161/CIRCRESAHA.115.306565

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diaz-Araya G, Vivar R, Humeres C, Boza P, Bolivar S, Munoz C (2015) Cardiac fibroblasts as sentinel cells in cardiac tissue: Receptors, signaling pathways and cellular functions. Pharmacol Res 101:30–40. https://doi.org/10.1016/j.phrs.2015.07.001

Article  CAS  PubMed  Google Scholar 

Stratton MS, Bagchi RA, Felisbino MB, Hirsch RA, Smith HE, Riching AS, Enyart BY, Koch KA, Cavasin MA, Alexanian M et al (2019) Dynamic chromatin targeting of BRD4 stimulates cardiac fibroblast activation. Circ Res 125:662–677. https://doi.org/10.1161/CIRCRESAHA.119.315125

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopez B, Gonzalez A, Diez J (2010) Circulating biomarkers of collagen metabolism in cardiac diseases. Circulation 121:1645–1654. https://doi.org/10.1161/CIRCULATIONAHA.109.912774

Article  PubMed  Google Scholar 

Thackeray JT, Derlin T, Haghikia A, Napp LC, Wang Y, Ross TL, Schafer A, Tillmanns J, Wester HJ, Wollert KC et al (2015) Molecular imaging of the Chemokine receptor CXCR4 after acute myocardial infarction. JACC Cardiovasc Imaging 8:1417–1426. https://doi.org/10.1016/j.jcmg.2015.09.008

Article  PubMed  Google Scholar 

Varasteh Z, Mohanta S, Robu S, Braeuer M, Li Y, Omidvari N, Topping G, Sun T, Nekolla SG, Richter A et al (2019) Molecular imaging of fibroblast activity after myocardial infarction using a (68)Ga-labeled fibroblast activation protein inhibitor, FAPI-04. J Nucl Med 60:1743–1749. https://doi.org/10.2967/jnumed.119.226993

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rieder F, Nagy LE, Maher TM, Distler JHW, Kramann R, Hinz B, Prunotto M (2025) Fibrosis: cross-organ biology and pathways to development of innovative drugs. Nat Rev Drug Discov. https://doi.org/10.1038/s41573-025-01158-9

Article  PubMed  Google Scholar 

Acharya A, Baek ST, Huang G, Eskiocak B, Goetsch S, Sung CY, Banfi S, Sauer MF, Olsen GS, Duffield JS et al (2012) The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 139:2139–2149. https://doi.org/10.1242/dev.079970

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grimaldi V, De Pascale MR, Zullo A, Soricelli A, Infante T, Mancini FP, Napoli C (2017) Evidence of epigenetic tags in cardiac fibrosis. J Cardiol 69:401–408. https://doi.org/10.1016/j.jjcc.2016.10.004

Article  PubMed  Google Scholar 

Rosa-Garrido M, Chapski DJ, Schmitt AD, Kimball TH, Karbassi E, Monte E, Balderas E, Pellegrini M, Shih TT, Soehalim E et al (2017) High-resolution mapping of chromatin conformation in cardiac myocytes reveals structural remodeling of the epigenome in heart failure. Circulation 136:1613–1625. https://doi.org/10.1161/CIRCULATIONAHA.117.029430

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stratton MS, Haldar SM, McKinsey TA (2017) BRD4 inhibition for the treatment of pathological organ fibrosis. F1000Res. https://doi.org/10.12688/f1000research.11339.1

Article  PubMed  PubMed Central  Google Scholar 

Dick SA, Macklin JA, Nejat S, Momen A, Clemente-Casares X, Althagafi MG, Chen J, Kantores C, Hosseinzadeh S, Aronoff L et al (2019) Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat Immunol 20:29–39. https://doi.org/10.1038/s41590-018-0272-2

Article  CAS  PubMed  Google Scholar 

Desogere P, Tapias LF, Hariri LP, Rotile NJ, Rietz TA, Probst CK, Blasi F, Day H, Mino-Kenudson M, Weinreb P et al (2017) Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aaf4696

Article  PubMed  PubMed Central  Google Scholar 

Lombardi R, Betocchi S, Losi MA, Tocchetti CG, Aversa M, Miranda M, D’Alessandro G, Cacace A, Ciampi Q, Chiariello M (2003) Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 108:1455–1460. https://doi.org/10.1161/01.CIR.0000090687.97972.10

Article  CAS  PubMed  Google Scholar 

Frangogiannis NG (2021) Cardiac fibrosis. Cardiovasc Res 117:1450–1488. https://doi.org/10.1093/cvr/cvaa324

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mueller J, Gaertner FC, Blechert B, Janssen KP, Essler M (2009) Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo. Mol Cancer Res 7:1078–1085. https://doi.org/10.1158/1541-7786.MCR-08-0538

Article  CAS  PubMed  Google Scholar 

Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, Moon YS, Davis GE, Brooks PC (2001) Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 154:1069–1079. https://doi.org/10.1083/jcb.200103111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aronoff MR, Hiebert P, Hentzen NB, Werner S, Wennemers H (2021) Imaging and targeting LOX-mediated tissue remodeling with a reactive collagen peptide. Nat Chem Biol 17:865–871. https://doi.org/10.1038/s41589-021-00830-6

Article  CAS  PubMed  Google Scholar 

Gonzalez-Santamaria J, Villalba M, Busnadiego O, Lopez-Olaneta MM, Sandoval P, Snabel J, Lopez-Cabrera M, Erler JT, Hanemaaijer R, Lara-Pezzi E et al (2016) Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction. Cardiovasc Res 109:67–78. https://doi.org/10.1093/cvr/cvv214